Abstract
We sought to evaluate differences in outcomes between double versus triple transarterial
chemoembolization (TACE). TACEs over a 1-year period were retrospectively reviewed
and divided into two groups: double and triple. Imaging response and complications
were made on a per-procedure basis. Student's t-test was used to calculate differences in continuous variables, and chi-square test
was used to calculate differences in categorical values.Overall tumor response was
similar between the two groups, and there were no significant differences in complications
between groups. Outcomes are similar between double and triple conventional TACE,
suggesting that adding a third drug may only contribute to cost.
Keywords
TACE - chemoembolization - regimen - dual therapy - triple therapy
